Manhattan Pharmaceuticals to Present at the 5th Annual North America Forum for Investing and Partnering in Biotech and Medtech
09 mars 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, March 9, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today that Douglas Abel, President and Chief Executive Officer, will present at the 5th Annual North America...
Manhattan Pharmaceuticals' President and CEO Named Panelist for Obesity Focus Session at BIO CEO & Investor Conference
10 févr. 2006 11h09 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Feb. 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today that Douglas Abel, president and chief executive officer, will be a panelist for the "Obesity:...
Manhattan Pharmaceuticals Names Alan Harris Chief Medical Officer
01 févr. 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Feb. 1, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced that Alan G. Harris, MD, PhD has been named Chief Medical Officer of the company.
Dr. Harris brings more...
Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa Trial
28 déc. 2005 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Dec. 28, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) reported that a Phase IIa study has been initiated with PTH (1-34), its experimental product for the topical...
Manhattan Pharmaceuticals to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
03 nov. 2005 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Nov. 3, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, the Company's President and Chief Executive Officer, will give a presentation on...
Manhattan Pharmaceuticals Chief Reviews Obesity Drug Candidate at New York Investment Conference
25 oct. 2005 16h24 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 25, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals Inc.'s (AMEX:MHA) Chief Executive Officer Douglas Abel said preliminary data from a small Phase I study of the company's experimental...
Manhattan Pharmaceuticals to Present At the PIPEs Conference 2005 In New York
25 oct. 2005 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 25, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced that Douglas Abel, President and Chief Executive Officer, will present at the PIPEs Conference 2005 on...
Manhattan Pharmaceuticals to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
20 oct. 2005 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will be presenting at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference on Tuesday, October 25th at...
CORRECTING and REPLACING -- Manhattan Pharmaceuticals Presents Preliminary Phase I Results of Experimental Obesity Drug
17 oct. 2005 09h42 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- A Manhattan Pharmaceuticals, Inc. (AMEX:MHA) news release issued today at 7:44 a.m. (ET) (Oct. 17, 2005) contained errors in the table of VAS scores. The...
Manhattan Pharmaceuticals Presents Preliminary Phase I Results of Experimental Obesity Drug
17 oct. 2005 07h44 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced preliminary results from two Phase I clinical trials of oleoyl-estrone (OE), an experimental, orally...